Common data elements for substance use disorders in electronic health records: the NIDA Clinical Trials Network experience

Addiction
Udi E GhitzaBetty Tai

Abstract

Electronic health records (EHRs) are essential in improving quality and enhancing efficiency of health-care delivery. By 2015, medical care receiving service reimbursement from US Centers for Medicare and Medicaid Services (CMS) must show 'meaningful use' of EHRs. Substance use disorders (SUD) are grossly under-detected and under-treated in current US medical care settings. Hence, an urgent need exists for improved identification of and clinical intervention for SUD in medical settings. The National Institute on Drug Abuse Clinical Trials Network (NIDA CTN) has leveraged its infrastructure and expertise and brought relevant stakeholders together to develop consensus on brief screening and initial assessment tools for SUD in general medical settings, with the objective of incorporation into US EHRs. Stakeholders were identified and queried for input and consensus on validated screening and assessment for SUD in general medical settings to develop common data elements to serve as shared resources for EHRs on screening, brief intervention and referral to treatment (SBIRT), with the intent of supporting interoperability and data exchange in a developing Nationwide Health Information Network. Through consensus of input from stakehol...Continue Reading

References

Jan 1, 1982·Addictive Behaviors·H A Skinner
Oct 23, 2002·Journal of General Internal Medicine·Carol E GolinNeil S Wenger
Feb 11, 2005·The New England Journal of Medicine·Richard Saitz
May 20, 2005·The New England Journal of Medicine·Raymund Schwan, John P Allen
Feb 20, 2007·Journal of Substance Abuse Treatment·Errol YudkoAdriana Fouts
Jan 6, 2009·Pediatrics·Kristin A BrinnerUNKNOWN American Health Information Community Personalized Health Care Workgroup
Mar 27, 2009·The New England Journal of Medicine·David Blumenthal
Jun 10, 2010·Health Affairs·Melinda Beeuwkes BuntinDavid Blumenthal
Jul 14, 2010·Archives of Internal Medicine·Peter C SmithRichard Saitz
Aug 9, 2011·Substance Abuse and Rehabilitation·Udi E GhitzaBetty Tai
Jan 1, 2011·Substance Abuse and Rehabilitation·Lianne Lian HuBetty Tai
Jan 1, 2012·Substance Abuse and Rehabilitation·Betty TaiH Westley Clark

❮ Previous
Next ❯

Citations

Jun 5, 2013·Social Work in Public Health·Mary Ellen MichelGeetha Subramaniam
Jan 3, 2013·Addiction·Alex H S Harris
Jan 3, 2013·Addiction·Betty TaiDavid Shide
Jan 3, 2013·Addiction·Duncan Raistrick
Jan 3, 2013·Addiction·Maree Teesson
Jul 19, 2014·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Patricia SchramSharon Levy
Jan 25, 2020·Journal of General Internal Medicine·Mikko SayreKatharine A Bradley
Mar 16, 2020·Computers, Informatics, Nursing : CIN·Carmen Mei, Kelly Vaez
Jun 8, 2021·Frontiers in Sociology·Ana VentuneacDavid C Perlman
Aug 2, 2021·Journal of the American Medical Informatics Association : JAMIA·Yizhao NiSarah Beal

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.